Angion Biomedica Corp.
Angion Biomedica Corp. (ANGN) Revenue
Annual & quarterly revenue history · segment & region breakdown
ANGN · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsAngion Biomedica Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Angion Biomedica Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Angion Biomedica Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Angion Biomedica Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ANGN revenue · 4 questionsANGN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Angion Biomedica Corp. SEC filings · GAAP · Angion Biomedica Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026